Cargando…
SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
The on-going global pandemic of COVID-19 is caused by SARS-CoV-2, which features a proofreading mechanism to facilitate the replication of its large RNA genome. The 3′-to-5′ exoribonuclease (ExoN) activity of SARS-CoV-2 non-structural protein 14 (nsp14) removes nucleotides misincorporated during RNA...
Autores principales: | Moeller, Nicholas H., Passow, Kellan T., Harki, Daniel A., Aihara, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415739/ https://www.ncbi.nlm.nih.gov/pubmed/36016411 http://dx.doi.org/10.3390/v14081790 |
Ejemplares similares
-
Chemoenzymatic
Synthesis of 3′-Deoxy-3′,4′-didehydro-cytidine
triphosphate (ddhCTP)
por: Lee, James H., et al.
Publicado: (2023) -
Interfering with nucleotide excision by the coronavirus 3’-to-5’ exoribonuclease
por: Chinthapatla, Rukesh, et al.
Publicado: (2022) -
Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease
por: Chinthapatla, Rukesh, et al.
Publicado: (2022) -
Antiviral metabolite 3′-deoxy-3′,4′-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19
por: Mehta, Ravi, et al.
Publicado: (2022) -
Activation of the SARS-CoV-2 NSP14 3′–5′ exoribonuclease by NSP10 and response to antiviral inhibitors
por: Riccio, Amanda A., et al.
Publicado: (2021)